• Product Namelithospermic acid
• Brief DescriptionInhibitors
• Purification99.00%
• Biological Activitylithospermic acid, a potent anti-HIV agent and Lithospermic acid shows anti-gonadotrophic and anti-thyroidal effects
• Target NameHIV Protease inhibitor
• CAS No. 28831-65-4
• Calculated MW 538.461
• Formulation C27H22O12
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Others
  SMILES:C1=CC(=C(C=C1C[C@H](C(=O)O)OC(=O)/C=C/C2=C3[C@@H]([C@H](OC3=C(C=C2)O)C4=CC(=C(C=C4)O)O)C(=O)O)O)O
  Pathways:Microbiology&virology; Proteases/Proteasome
  Receptor:HIV
  Boling pt:
  Melting pt:
  Solubility:Pyridine, Methanol, Ethanol, etc.
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1.Xiuli W, Wei G, Mao S.Pharmacokinetic investigation on interaction between hydrophilic lithospermic acid B and lipophilic tanshinone IIA in rats: an experi- mental study.J Tradit Chin Med. 2015 Apr;35(2):206-10.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting